A myeloid IFN gamma response gene signature correlates with cancer prognosis
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Yuchao Zhang, Asma Khanniche, Yizhe Li, Zhenchuan Wu, Hailong Wang, Hongyu Zhang, Xiaoxue Li, Landian Hu, Xiangyin Kong |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Mutations of epigenetic genes and correlation with treatment response in peripheral T‐cell lymphoma
por: Chong Wei, et al.
Publicado: (2024)
por: Chong Wei, et al.
Publicado: (2024)
Multi‐omics analysis of pyroptosis‐related genes for prognosis and immune landscape in head and neck cancer
por: Shikang Zheng, et al.
Publicado: (2024)
por: Shikang Zheng, et al.
Publicado: (2024)
Synthetic lethality in cancer therapy: Mechanisms, models and clinical translation for overcoming therapeutic resistance
por: Junyan Li, et al.
Publicado: (2026)
por: Junyan Li, et al.
Publicado: (2026)
An exosome‐based liquid biopsy signature for therapeutic response prediction in metastatic gastric cancer
por: Keisuke Okuno, et al.
Publicado: (2024)
por: Keisuke Okuno, et al.
Publicado: (2024)
Targeting lysine methyltransferase 2C deficiency: New frontiers in breast cancer therapy and prognosis
por: Shuangmei Tong, et al.
Publicado: (2026)
por: Shuangmei Tong, et al.
Publicado: (2026)
NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence
por: Marina Mendiburu‐Eliçabe, et al.
Publicado: (2024)
por: Marina Mendiburu‐Eliçabe, et al.
Publicado: (2024)
Id2 exacerbates the development of rheumatoid arthritis by increasing IFN‐γ production in CD4+ T cells
por: Haoyang Sun, et al.
Publicado: (2025)
por: Haoyang Sun, et al.
Publicado: (2025)
SAA1 and metabolomic signatures predict hyperprogression with immunotherapy in pan cancers
por: Xiaoqing Wang, et al.
Publicado: (2024)
por: Xiaoqing Wang, et al.
Publicado: (2024)
Targeting biomolecular condensates to inhibit breast cancer
por: Xiaoxue Zhou, et al.
Publicado: (2025)
por: Xiaoxue Zhou, et al.
Publicado: (2025)
Alterations of the immune microenvironment with age predicts patient prognosis of gastrointestinal tract tumours
por: Fangzhen Li, et al.
Publicado: (2026)
por: Fangzhen Li, et al.
Publicado: (2026)
Baseline multi‐omics signatures could predict therapeutic response to neoadjuvant anti‐PD‐1 immunochemotherapy in non‐small‐cell lung cancer
por: Ailing Cao, et al.
Publicado: (2026)
por: Ailing Cao, et al.
Publicado: (2026)
O‐GlcNAcylation promotes malignancy and cisplatin resistance of lung cancer by stabilising NRF2
por: Yihan Zhang, et al.
Publicado: (2024)
por: Yihan Zhang, et al.
Publicado: (2024)
CAR‐DC combined with CAR‐T therapy for relapsed/refractory acute myeloid leukaemia: Research progress and future perspectives
por: Rui Zhang, et al.
Publicado: (2025)
por: Rui Zhang, et al.
Publicado: (2025)
Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple‐negative breast cancer patients
por: Chiara Massa, et al.
Publicado: (2024)
por: Chiara Massa, et al.
Publicado: (2024)
Analysis of hepatitis B virus integration identifies KMT2B as a novel cancer‐related gene in pancreatic cancer
por: Mengge Li, et al.
Publicado: (2025)
por: Mengge Li, et al.
Publicado: (2025)
Reduction of myeloid‐derived suppressor cells in prostate cancer murine models and patients following white button mushroom treatment
por: Xiaoqiang Wang, et al.
Publicado: (2024)
por: Xiaoqiang Wang, et al.
Publicado: (2024)
Progression significance for low‐level aberrant B‐lymphoblasts in chronic myeloid leukaemia patients
por: Haoren Wang, et al.
Publicado: (2025)
por: Haoren Wang, et al.
Publicado: (2025)
PVT1‐104aa derived from the 8q24 gene desert promotes colorectal cancer tumorigenesis
por: Maoguang Ma, et al.
Publicado: (2026)
por: Maoguang Ma, et al.
Publicado: (2026)
Multi‐omics molecular phenotyping reveals the potential mechanisms of chemotherapy response and resistance in small cell lung cancer
por: Ying Cheng, et al.
Publicado: (2024)
por: Ying Cheng, et al.
Publicado: (2024)
Predictive nomogram integrating radiomics and multi‐omics for improved prognosis‐model in cholangiocarcinoma
por: Yunlu Jia, et al.
Publicado: (2025)
por: Yunlu Jia, et al.
Publicado: (2025)
A new paradigm for cancer immunotherapy: Orchestrating type 1 and type 2 immunity for curative response
por: Bing Feng, et al.
Publicado: (2024)
por: Bing Feng, et al.
Publicado: (2024)
Targeting the nuclear export receptor exportin‐1 in acute myeloid leukaemia: From biology to clinical translation
por: Yifan Liu, et al.
Publicado: (2026)
por: Yifan Liu, et al.
Publicado: (2026)
A novel computational tool for tracking cancer energy hijacking from immune cells
por: Hongyi Zhang, et al.
Publicado: (2024)
por: Hongyi Zhang, et al.
Publicado: (2024)
Targeting the chromatin remodelling protein Brahma‐related gene 1 for intervention of pulmonary fibrosis
por: Teng Wu, et al.
Publicado: (2024)
por: Teng Wu, et al.
Publicado: (2024)
Transcriptomic miRNA and mRNA signatures in primary prostate cancer that are associated with lymph‐node invasion
por: Matias A. Bustos, et al.
Publicado: (2025)
por: Matias A. Bustos, et al.
Publicado: (2025)
Farletuzumab ecteribulin and MORAb‐109, folate receptor alpha and mesothelin targeting antibody–drug conjugates, show activity in poor prognosis gynaecological cancer models
por: Ksenija Nesic, et al.
Publicado: (2025)
por: Ksenija Nesic, et al.
Publicado: (2025)
Unravelling the distinct effects of VHL mutations and chromosome 3p loss in clear cell renal cell carcinoma: Implications for prognosis and treatment
por: Xiang Wang, et al.
Publicado: (2025)
por: Xiang Wang, et al.
Publicado: (2025)
Comprehensive multi‐omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single‐center, open‐label, single‐arm phase II trial
por: Yuzhou Zhao, et al.
Publicado: (2024)
por: Yuzhou Zhao, et al.
Publicado: (2024)
Vitamin K‐dependent gamma‐carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosine kinase receptor EGFR
por: Zheng Wu, et al.
Publicado: (2025)
por: Zheng Wu, et al.
Publicado: (2025)
Immune‐based transcriptomic signature predicts CDK4/6 inhibitor efficacy in HR+/HER2– breast cancer
por: Eudald Felip, et al.
Publicado: (2025)
por: Eudald Felip, et al.
Publicado: (2025)
A plasma‐derived exosomal microRNA signature by small RNA sequencing for early detection of postmenopausal osteoporosis
por: Pan Gao, et al.
Publicado: (2024)
por: Pan Gao, et al.
Publicado: (2024)
A multi‐omic biomarker signature in pre‐treatment rectal tumours stratifies patients with different pathological responses to neoadjuvant treatment
por: Laura E. Kane, et al.
Publicado: (2025)
por: Laura E. Kane, et al.
Publicado: (2025)
Detection, molecular function and mechanisms of m5C in cancer
por: Linhui Zhang, et al.
Publicado: (2025)
por: Linhui Zhang, et al.
Publicado: (2025)
KMT2C/D mutations in newly diagnosed acute myeloid leukaemia: Clinical features, genetic co‐occurrences and prognostic significance
por: Wenting Wang, et al.
Publicado: (2025)
por: Wenting Wang, et al.
Publicado: (2025)
Low methylthioadenosine phosphorylase expression is associated with worse survival in patients with acute myeloid leukaemia
por: Yiyu Xiao, et al.
Publicado: (2024)
por: Yiyu Xiao, et al.
Publicado: (2024)
Exploring the potential role of oxidative stress‐related genes in colorectal cancer recurrence and establishing a recurrence assessment system based on single‐cell and bulk RNA‐seq analysis
por: Xin Gao, et al.
Publicado: (2024)
por: Xin Gao, et al.
Publicado: (2024)
CircHPCAL1 promotes the progression of pancreatic cancer via the regulation of STEAP2
por: Xiaomeng He, et al.
Publicado: (2025)
por: Xiaomeng He, et al.
Publicado: (2025)
Multi‐omics predictive model based on clinical, radiomic and genomic features for predicting the response of limited‐stage small cell lung cancer to definitive chemoradiotherapy
por: Li Li, et al.
Publicado: (2024)
por: Li Li, et al.
Publicado: (2024)
The co‐location of CD14+APOE+ cells and MMP7+ tumour cells contributed to worse immunotherapy response in non‐small cell lung cancer
por: Guangyu Fan, et al.
Publicado: (2024)
por: Guangyu Fan, et al.
Publicado: (2024)
PCDHGB7 inhibits the progression of triple‐negative breast cancer by suppressing XRCC5/MYC‐mediated ribosome biogenesis
por: Ming Shan, et al.
Publicado: (2025)
por: Ming Shan, et al.
Publicado: (2025)
Ejemplares similares
-
Mutations of epigenetic genes and correlation with treatment response in peripheral T‐cell lymphoma
por: Chong Wei, et al.
Publicado: (2024) -
Multi‐omics analysis of pyroptosis‐related genes for prognosis and immune landscape in head and neck cancer
por: Shikang Zheng, et al.
Publicado: (2024) -
Synthetic lethality in cancer therapy: Mechanisms, models and clinical translation for overcoming therapeutic resistance
por: Junyan Li, et al.
Publicado: (2026) -
An exosome‐based liquid biopsy signature for therapeutic response prediction in metastatic gastric cancer
por: Keisuke Okuno, et al.
Publicado: (2024) -
Targeting lysine methyltransferase 2C deficiency: New frontiers in breast cancer therapy and prognosis
por: Shuangmei Tong, et al.
Publicado: (2026)